FDA Stance On Antidepressant Warnings Unchanged By NIMH Suicide Findings
Executive Summary
A National Institute of Mental Health-funded study showing no increased risk of suicide with newer antidepressants does not change FDA's stance on the need for warnings about suicidality for the drug class